Cargando…
Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series
Autores principales: | Kanda, Yoshinobu, Mori, Takehiko, Narita, Atsushi, Wolter, Kevin D., Yoshimatsu, Hiroki, Nishimura, Kazuma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971063/ https://www.ncbi.nlm.nih.gov/pubmed/36696019 http://dx.doi.org/10.1007/s12185-023-03543-9 |
Ejemplares similares
-
Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series
por: Kanda, Yoshinobu, et al.
Publicado: (2022) -
Aplastic Anemia Preconditioned with Fludarabine, Cyclophosphamide, and Anti-Thymocyte Globulin
por: Yang, Dan, et al.
Publicado: (2019) -
Aplastic Anemia with Epstein-Barr Virus Reactivation after Anti-thymocyte Globulin Therapy
por: Kawarada, Yo, et al.
Publicado: (2023) -
Anti-Thymocyte Globulin (ATG)-Free Nonmyeloablative Haploidentical PBSCT Plus Post-Transplantation Cyclophosphamide Is a Safe and Efficient Treatment Approach for Pediatric Acquired Aplastic Anemia
por: Chen, Rong-Long, et al.
Publicado: (2022) -
EATG training academy STEP-UP: skills training to empower patients
por: Martynenko, Oleksandr, et al.
Publicado: (2014)